NMPA Approval

Atilotrelvir Tablets/Ritonavir Tablets（co-packaged）

Approval Number

国药准字H20230029

Company福建广生中霖生物科技有限公司

Registration Date

November 23, 2023

Drug Information

Generic Name

阿泰特韦片/利托那韦片组合包装

Trade Name

泰中定

Dosage Form

片剂

Strength

阿泰特韦片0.15g/利托那韦片0.1g

Drug Type

化学药品

Registration Date

November 23, 2023

Company Information

Applicant Company

Company Name福建广生中霖生物科技有限公司

Company Address

福建省宁德市柘荣县富源工业园区1-7幢综合办公楼2层

Manufacturing Company

Company Name福建广生堂药业股份有限公司

Company Address

福建省宁德市柘荣县富源工业园区1-7幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

阿泰特韦片/利托那韦片组合包装 - NMPA 批准文号 | MedPath